-

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against CSX Corporation (CSX)

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against CSX Corporation (“CSX” or the “Company”) (NASDAQ: CSX). The investigation concerns whether CSX and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

[Click here to learn more about the investigation]

On October 17, 2024, Bloomberg published an article stating that CSX “received a subpoena from the US Securities and Exchange Commission” relating to “previously disclosed accounting errors and certain non-financial performance metrics.” According to the Bloomberg article, “The subpoena asked the railroad company to produce documents about accounting mistakes CSX disclosed in its previous quarterly report, according to a regulatory filing on Thursday. The company received the subpoena this month and is cooperating with the probe, CSX said in the filing.” On this news, the price of CSX shares declined by $2.38 per share from $35.47 per share on October 17, 2024, to close at $33.09 on October 18, 2024.

If you purchased or otherwise acquired CSX securities, have information, or would like to learn more about this investigation, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this CONTACT FORM, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

Kirby McInerney LLP

NASDAQ:CSX

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

More News From Kirby McInerney LLP

INVESTOR ALERT: Securities Class Action Filed Against Richtech Robotics Inc. – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Richtech Robotics Inc. (“Richtech” or the “Company”) (NASDAQ:RR) securities during the period of January 27, 2026 through January 29, 2026, inclusive (“the Class Period”). If you suffered a loss on your Richtech investments, you have until April 3, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications sub...

INVESTOR ALERT: Securities Class Action Filed Against Ramaco Resources, Inc. – Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Ramaco Resources, Inc. (“Ramaco” or the “Company”) (NASDAQ:METC) securities during the period of July 31, 2025 through October 23, 2025, inclusive (“the Class Period”). If you suffered a loss on your Ramaco investments, you have until March 31, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitt...

REMINDER: Ardent Health, Inc. Investors With Significant Losses Must Act By March 9, 2026

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE:ARDT) investors of the March 9, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead p...
Back to Newsroom